CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.
Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .
Resultado final
This report describes current policies at the European and if useful national levels that guide or determine the development of new drugs against COVID19
Report on collaborations and impact assessment (se abrirá en una nueva ventana)This reports describes the first activities with other research and innovation initiatives and established contacts as well as an impact assessment of these An updated version will be submitted at the end of the projectA brief report on the main outcomes of the meeting with the European COVID19 clinical trial network for therapeutics covid19trialseu and possible followup actions will be considered Upon availability of clinical trial data that would allow further evaluation in Phase II clinical trials of the developed therapeutic compounds the coordinator will contact the European COVID19 clinical trial network for therapeutics covid19trialseuecrinorg to explore the compounds suitability for the European network of largescale multicentre clinical trials for hospitalized patients covid19trialseu
"Report on virtual meeting with the other successful projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01" (se abrirá en una nueva ventana)A virtual meeting will be set up by DG RTD in coordination with HaDEA between the projects working on COVID19 therapeutics funded under the Horizon Europe call HORIZONHLTH2021CORONA01 at the beginning of the projects lifetime This meeting is to introduce each project to each other and to identify areas for potential collaboration The brief report submitted shall include the minutes of the meeting and a plan on how to move forward in identified possible areas of collaboration Participation of the coordinators of the European COVID19 clinical trial network for therapeutics covid19trialseu will be considered for this meeting to introduce the relevant adaptive platform trials
Analysis of barriers for uptake (se abrirá en una nueva ventana)This report describes possible barriers related to the future update of the FX06based therapy by clinical staff and other stakeholder groups
Interim impact report (se abrirá en una nueva ventana)This report describes the results of an assessment of the communication and dissemination measures impact
Governance Report (se abrirá en una nueva ventana)This report describes the organisational structure of the project management the roles and responbilities of the consortium bodies as defined in the Consortium Agreement
Training material (se abrirá en una nueva ventana)This report describes the types structure and content of training material to be used for the training of clinical staff before and during the implementation of the clinical study
"Progress report on the collaborative actions between the projects working on COVID-19 therapeutics funded under the Horizon Europe call ""HORIZON-HLTH-2021-CORONA-01""" (se abrirá en una nueva ventana)The brief report will provide an update on the collaborative efforts that were undertaken in the first 18 months of the pro-jects’ duration, also according to what was laid in D1.7.
Plan for dissemination including communication activities (se abrirá en una nueva ventana)This report describes the aims the strategy and the planned measures related to the communication and dissemination of the project and its results
The project website documentation covers technical aspects the first website structure and initial content
Publicaciones
Autores:
Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak-Schadendorf, Anita; Vehreschild, Maria J. G. T.; Matos, Francisco Maio; Riera-Mestre, Antoni; van Asselt, Antoinette D. I.; De Robertis, Edoardo; Juskeviciene, Vilma Traskaite; Meybohm, Patrick; Tomescu, Dana; Lacombe, Karine; Stehouwer, Coen D. A.; Zacharowski, Kai
Publicado en:
2022, ISSN 0967-0912
Editor:
Institute of Materials
DOI:
10.6084/m9.figshare.20521689
Autores:
Jan Andreas Kloka; Benjamin Friedrichson; Petra Wülfroth; Rainer Henning; Kai Zacharowski
Publicado en:
Cells, Vol 12, Iss 10, p 1345 (2023), 2023, ISSN 2073-4409
Editor:
MDPI
DOI:
10.3390/cells12101345
Autores:
Clazinus Veijer; Marinus H. van Hulst; Benjamin Friedrichson; Maarten J. Postma; Antoinette D.I. van Asselt
Publicado en:
PharmacoEconomics, 2024, ISSN 1170-7690
Editor:
Adis International Ltd
DOI:
10.1007/S40273-024-01375-X
Autores:
Värri, A. O., Kallonen, A., Asuroglu, T., & van Gils, M.
Publicado en:
Finnish Journal of eHealth and eWelfare, 2023, ISSN 1798-0798
Editor:
Finnish Social and Health Informatics Association
DOI:
10.23996/fjhw.126881
Autores:
Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak Schadendorf, Anita; Vehreschild, Maria J. G. T.; Matos, Francisco Maio; Riera Mestre, Antoni; Van Asselt, Antoinette D. I.; De Robertis, Edoardo; Juskeviciene, Vilma
Publicado en:
Trials, 23(1):688. BioMed Central Ltd, 2022, ISSN 1745-6215
Editor:
Trials
DOI:
10.1186/s13063-022-06609-x
Buscando datos de OpenAIRE...
Se ha producido un error en la búsqueda de datos de OpenAIRE
No hay resultados disponibles